NFKB1 and inflammatory bowel disease: For example, curcumin, a bioactive ingredient, has been found in studies on IBD patients to significantly reduce intestinal inflammation through the inhibition of the NF-κB signaling pathway and the activity of p38 mitogen-activated protein kinase (MAPK) (161).